← Back to Clinical Trials
Recruiting NCT07229508

NCT07229508 Developmental Trajectories of Reinforcer Pathology and Childhood Obesity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07229508
Status Recruiting
Phase
Sponsor State University of New York at Buffalo
Condition Pediatric Obesity
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2025-11-06
Primary Completion 2030-10-01

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 11 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2025-11-06 with a primary completion date of 2030-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to understand how children's food preferences, physical activity, and decision-making change over time and how these behaviors relate to body weight and overall health.

Eligibility Criteria

Inclusion Criteria: * Male and female children * Black, Indigenous, and People of Color (BIPOC) or Hispanic families * Children from low SES families (as defined by household education, eligibility for government assistance) * Children in overweight/obese category (defined by range in each cohort) Exclusion Criteria: * Medical causes for obesity * Stature below the 5th percentile * Physical activity restrictions * Psychopathology * Medication use that affects activity or appetite * Children that spend less than 65% of their time in participating parent's household * BMI percentile criteria * Liking of study foods and activities * Dietary restrictions and food allergies

Contact & Investigator

Central Contact

Mary J Hite, BA

✉ maryjohi@buffalo.edu

📞 7168292261

Principal Investigator

Leonard H Epstein, PhD

PRINCIPAL INVESTIGATOR

SUNY-University at Buffalo

Frequently Asked Questions

Who can join the NCT07229508 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 11 Years, studying Pediatric Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07229508 currently recruiting?

Yes, NCT07229508 is actively recruiting participants. Contact the research team at maryjohi@buffalo.edu for enrollment information.

Where is the NCT07229508 trial being conducted?

This trial is being conducted at Buffalo, United States.

Who is sponsoring the NCT07229508 clinical trial?

NCT07229508 is sponsored by State University of New York at Buffalo. The principal investigator is Leonard H Epstein, PhD at SUNY-University at Buffalo. The trial plans to enroll 250 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology